• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMGEN INC. ON-BODY INJECTOR; NEULASTA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMGEN INC. ON-BODY INJECTOR; NEULASTA Back to Search Results
Health Effect - Clinical Code No Information (3190)
Date of Event 08/28/2017
Type of Reportable Event Serious Injury
Event or Problem Description
Neulasta on body injector fell off of patient at home.Dates of use: (b)(6)2017.Diagnosis or reason for use: drug induced neutropenia.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-BODY INJECTOR
Common Device Name
NEULASTA
Manufacturer (Section D)
AMGEN INC.
MDR Report Key6839086
Report NumberMW5071911
Device Sequence Number1121736
Product Code NSC
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 08/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date09/01/2017
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age63 YR
Patient Weight74
-
-